Table: Wakamoto Pharm - 6-MTH parent results

Wakamoto Pharmaceutical

06/11/2023 06:00

Nov 6 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             3.62                4.02                      
                 (-10.0 pct)         (+0.3 pct)                   
  Operating     loss 328 mln         loss 85 mln                  
  Recurring     loss 319 mln         loss 27 mln                  
  Net           loss 222 mln         loss 21 mln                  
  EPS           loss 6.42 yen       loss 0.62 yen                 
  Ann Div                             3.00 yen                    
  -Q2 div            NIL                 NIL                      
  -Q4 div                             3.00 yen                    
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T